NLS PHARMACEUTICS LTD's ticker is NLSPW and the CUSIP is H57830111. A total of 6 filers reported holding NLS PHARMACEUTICS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $239,807 | +15.8% | 826,921 | -0.1% | 0.08% | +23.4% |
Q3 2022 | $207,000 | +109.1% | 827,421 | 0.0% | 0.06% | +146.2% |
Q2 2022 | $99,000 | -91.5% | 827,421 | -0.1% | 0.03% | -90.9% |
Q1 2022 | $1,167,000 | +27.0% | 827,921 | 0.0% | 0.29% | +2.1% |
Q4 2021 | $919,000 | -55.6% | 827,921 | 0.0% | 0.28% | -35.6% |
Q3 2021 | $2,069,000 | +137.3% | 827,921 | 0.0% | 0.44% | +177.1% |
Q2 2021 | $872,000 | – | 827,921 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 827,921 | $2,069,000 | 0.44% |
Worth Venture Partners, LLC | 194,560 | $161,000 | 0.07% |
ARMISTICE CAPITAL, LLC | 500,000 | $413,000 | 0.01% |
Warberg Asset Management LLC | 35,480 | $29,000 | 0.01% |
Hudson Bay Capital Management LP | 200,000 | $154,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
UBS Group AG | 2,635 | $2,000 | 0.00% |
Bank Julius Baer & Co. Ltd, Zurich | 7,370 | $6,000 | 0.00% |